Literature DB >> 11710885

Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations.

Y Su, M Swift.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710885     DOI: 10.1001/jama.286.18.2233-a

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

Authors:  Jonine L Bernstein; Robert W Haile; Marilyn Stovall; John D Boice; Roy E Shore; Bryan Langholz; Duncan C Thomas; Leslie Bernstein; Charles F Lynch; Jorgen H Olsen; Kathleen E Malone; Lene Mellemkjaer; Anne-Lise Borresen-Dale; Barry S Rosenstein; Sharon N Teraoka; Anh T Diep; Susan A Smith; Marinela Capanu; Anne S Reiner; Xiaolin Liang; Richard A Gatti; Patrick Concannon
Journal:  J Natl Cancer Inst       Date:  2010-03-19       Impact factor: 13.506

Review 2.  Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review.

Authors:  K J Jerzak; T Mancuso; A Eisen
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

3.  Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions.

Authors:  Noriko Hosoya; Kiyoshi Miyagawa
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

4.  Tolerability of Breast Radiotherapy Among Carriers of ATM Germline Variants.

Authors:  Leslie A Modlin; Jessica Flynn; Zhigang Zhang; Oren Cahlon; Boris Mueller; Atif J Khan; Erin F Gillespie; Beryl McCormick; Zsofia K Stadler; Mark E Robson; Simon N Powell; Lior Z Braunstein
Journal:  JCO Precis Oncol       Date:  2021-01-19

5.  ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data.

Authors:  Nalee Kim; Se Hoon Kim; Seok-Gu Kang; Ju Hyung Moon; Jaeho Cho; Chang-Ok Suh; Hong In Yoon; Jong Hee Chang
Journal:  Radiat Oncol       Date:  2020-07-31       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.